Bempikibart (ADX-914) is a fully human anti-IL-7Ralpha antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and thymic stromal lymphopoietin (TSLP). Bempikibart can be used for the study of atopic dermatitis and alopecia areata[1].
Molecular Weight:
(145.745 kDa)
Purity:
98.00
CAS Number:
[2622254-57-1]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted